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Abstract  
The recent introduction of the Heptavalent-pneumococcal vaccine (PCV-7) by private pharmaceutical companies in Nigeria, has generated interest 
in invasive bacterial diseases particularly IPD. Our objective in this study is to investigate the trend and occurrence rate of IPD in Abeokuta, 
Nigeria. Suspected IPD cases were assessed from Jan 2010 to Dec 2010 for demographic and Microbiological characteristics. Bacterial isolations 
and antibiotics susceptibility testing followed standard bacteriological procedure. Overall 471 cases of probable IPD was assessed, with 21(4.5%) 
cases of suspected pneumonia, 109(23.1%) cases of suspected meningitis, and 341(72.4%) cases of suspected septicaemia. Confirmed IPD cases 
were 9 with 2 cases of meningitis, 3 cases of septicaemia and 4 cases of pneumonia. Age range distribution showed, high distribution of IPD cases 
among children >1 with 5(55.6%) there was a statistically significant difference in gender p< 0.05 (X2 test) with females recording a higher 
occurrence than males. We conclude by advocating for better detection methods against IPD meningitis cases, and continuous surveillance into the 
serotypes of streptococcus pneumonia as well inclusion of the PCV vaccine into our childhood immunization program. 
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Streptococcus pneumoniae or pneumococcus is a gram positive 
cocci bacterium responsible for a variety of infectious diseases, 
some of which are very invasive and life threatening such as 
Meningitis, Pneumonia and blood stream infections. They are 
responsible for over 4 million illnesses in the United States alone 
[1]. Reports have also shown that S. pneumoniae are responsible 
for over 1 million deaths of > 5 children annually [2]. The 
introduction of the 23-valent polysaccharide vaccine giving 
protective coverage to 23 serotypes to the over 90 circulating 
serotypes gave a relive by its protective role against Invasive 
Pneumococcal Disease (IPD) in most at-risk children in developed 
countries [3]. Reports of insufficient immunogenicity and insufficient 
protective coverage particularly in infants lead in 2001 to the 
introduction of the improved heptavalent pneumococcal-conjugate 
vaccine PCV-7 which is more immunogenic and offers good 
coverage against the commonest serotypes of s. pneumoniae, 4, 
6B, 9V, 14, 18C, 19F and 23F in childhood immunization programs 
in most developed countries [3,4]. Since the introduction of the PCV 
vaccine in childhood immunization programs, implementing 
countries have experienced a reduction in mortality caused by IPD 
and a reduced incidence rate in the number of IPD cases [4]. Owing 
to the limited coverage capacity of PCV-7, there have been reports 
of increase in IPD cases caused by non PCV-7 serotypes [5,6]. In 
Nigeria there is reported evidence of relatively high IPD related 
disease burden, a recent study in Ibadan, revealed that 39.3% of a 
total of 1210 cases of probable IPD were meningitis and 33% of 
that figure were pneumonia [2]. The recent introduction of the PCV 
vaccine by Glasgow Smithkline (GSK) a multi-national 
pharmaceutical company in Nigeria seems to bring relief, but the 
high cost of procurement has seem to put it out of the reach of the 
most at risk population. The introduction of the PCV in Nigeria still 
needs government intervention as it is yet to be included in EPI 
(Expanded program on Immunization) program. Research into the 
actual disease burden and epidemiological pattern including the 
most prevailing serotypes in Nigeria needs to be stepped up, with 
the introduction of this new vaccine. Our objective has been 
motivated by this need, this study was conducted to retrospectively 
review IPD cases, and their demographic and bacteriological pattern 





Study site and study design 
  
The study was carried out at the Federal Medical Centre, Abeokuta, 
Ogun State, Nigeria. The hospital is a growing tertiary Institution 
with about 400 beds and specialist wards including a functional 
pediatric ward and pediatric intensive care unit. The hospitals serves 
as a referral centre for Ogun state and neighboring Lagos State, 
because of the teeming population of Lagosians. The study is a 
review of all suspected and Laboratory confirmed IPD cases in F.M.C 
Abeokuta from January 2010 to December 2010. Relevant 
information was retrieved from laboratory records of the Medical 
Microbiology and Parasitology Unit of the Center. All information 
regarding patient's data was accorded the highest level of 
confidentiality in accordance to the Belmont report (Document of 







For this study clinical definitions were used, for a suspected or 
probable case of IPD, it was defined as any case of Pneumonia, 
Septicaemia or Meningitis, followed up by a Microbiology analysis 
but without a positive culture result or with a positive culture result 
not yielding Streptococcus pneumoniae. A confirmed IPD case was 
defined as a suspected case of Pneumonia, septicaemia, or 
Meningitis yielding a positive culture result with Streptococcus 
pneumoniae, from a normally sterile site such as blood or 




All samples were processed at the Medical Microbiology Unit of 
F.M.C. Abeokuta. Samples submitted fro processing included, 
cerebrospinal fluid, (c.s.f), blood, pleural aspirate. For c.s.f samples, 
the sample was examined macroscopically for appearance, volume 
and presence of blood. Microscopic examination was done by wet 
preparation for presence of leucocytes, and direct gram stain for 
demonstration of bacteria. The c.s.f sample was then cultured 
according to standard bacteriologic procedure [8] and isolates were 
identified as Streptococus.p by haemolysis on blood agar (Sheep 
blood) and susceptibility to optocin [8]. For blood, inoculated blood 
culture bottles were incubated at 370C for 4 to 7 days with 3 sub 
cultures as previously described [9]. All isolates were identified 
using standard microbiology techniques [8]. Pleural aspirate was 
processed following standard bacteriological technique. All isolates 
were tested for antibiolotic susceptibility following the Kirby-Bauer 
method and results were interpreted using CLSI break points [8, 
10]. 
  
Statistical analysis: Data generated was, averaged and organized 
into tables, comparisons were made using the chi square test for 






During the period under review, a total of 471 cases of probable 
IPD, with a total of 21(4.5%) cases of suspected pneumonia, 
109(23.1%) cases of suspected meningitis, and 341(72.4%) cases 
of suspected septicaemia. The number of confirmed cases are 
shown in Figure 1 with 6(5%) cases of pneumonia 7(5.9%) of 
meningitis and 106(89.1%) of confirmed septicaemia. The 
demographic distribution containing age and gender distribution of 
probable IPD cases and IPD confirmed cases reveals that, they were 
almost twice as more females than males who presented with 
probable IPD cases with males recording 187(39.7%) and females 
284(60.3%) age group distribution showed that less than 1 year old 
children consisted more than half of the total probable IPD cases 
with 263(55.8%) age group 1 > 15 recorded 173(36.7%) and lastly 
15 and above with 35(7.5%) details of confirmed cases are shown 
in Table 1. Distribution of isolated microorganisms from various 
invasive bacterial diseases including IPD cases in relation to 
diagnosis is shown below in Table 2 with Streptococcus pneumonia 
recording 3(2.7%) isolation rate against septicaemia, 4(66.7%) of 
total isolation against pneumonia and 2(33.3%) of total isolation 
against meningitis. Staphylococcus aureus recorded 44(41.5%) of 
total isolations against septicemia making it the highest bacteria 
species isolated in the reviewed invasive bacterial diseases, no 
isolations of s.aureus were made against pneumonia and 2(33.3%) 
isolation was recorded amongst meningitis cases. Details of other 
bacteria isolations such as escherichai coli, klebsiela pneumomiae 
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and other types of bacteria are shown in Table 2 below. Table 3 
shows the antibiotic susceptibility pattern of the 9 isolates of s. 





Our study highlights the occurrence rate of suspected IPD cases in 
Abeokuta, Nigeria remains high with our current estimate reaching 
471 cases through the year 2010. This is much lower than that of a 
recent multi-centre study done at Ibadan which reported about 171 
probable cases with 21 culture confirmed cases [2]. The number of 
culture positive cases in our study is about a third of the number of 
specimens received (119 cases) judging that each case patient 
submitted at least one culture sample for processing. The number of 
culture confirmed cases in our study 9(7.6%), seems unrealistically 
low comp aired to some reports from advanced countries [7, 11]. 
The very low recovery rate of the incriminating pathogen however is 
not unique to our own study setting as very low recovery rates were 
also observer in a study done at Ibadan, within the same geo-
political zone as ours [2]. Factors responsible for low rates observed 
in our current study include antibiotic usage prior to sample 
collection, poor communication and sample transportation 
particularly for C.S.F samples, and low sensitivity rate with the 
culture techniques used, for instance human blood was used instead 
of sheep blood in preparing the media used for isolation of 
pathogens. Similar constraints have been previously reported [2] in 
our environment; this has made it difficult to make any justifiable 
comparison to other studies done outside our environment. 
Septicaemia was the most frequently diagnosed disease with 
314(72.4%) cases, followed by Meningitis 109(23.1%) of diagnosed 
cases Pneumonia was the least observed case, this is in agreement 
with the report of Falade et al., [2] which recorded a higher 
Meningitis case detection rate than pneumonia, this observed trend 
is also concomitant to other reports that gave the same trend 
[7, 11]. Demographic distribution shows that females recorded a 
higher occurrence rate than males, p < 0.05 (Chi square test), this 
might be strictly co-incidental, because previous reports have 
indicated male gender is a risk factor for severe Respiratory 
Syncytial virus (RSV) infection [12]. Age group distribution revealed 
that children of > 1yr old were the most affected with 263(55.8%) 
of probable cases and 5(55.6%) of culture confirmed cases, this is 
in agreement with the report of Shaidi et al. [3], but is not with 
agreement with another report that indicated a higher infection rate 
in the elderly above 65 years old in the Netherlands [4]. 
Surveillance data have shown that majority of Invasive respiratory 
diseases are higher at the 2 extremes of life, however we do not 
know exactly why a low rate was observed in our current study, it is 
worthy of note to mention that many of the senior citizens' in our 
environment because of financial constrains and ethno-religious 
beliefs do not visit the hospital until when situations gets out of 
hand. 
  
Perhaps a more robust cohort study is needed to investigate this 
finding. The occurrence rate of recovered bacteria isolates in our 
current study shows that Septicaemia had the highest recovery rate, 
with staphylococcus aureus being the commonest pathogen, this 
could be as a result of sample contamination, although in the 
current study proper care was taken to reduce the incidence of 
contamination among our samples. Pneumonia cases however had 
streptococcus pneumonia being the most frequently recovered 
isolate. A major limitation which would have had added significant 
epidemiological value to this work was our inability to demonstrate 
the existing serotypes of S. pneumonia strains. Our laboratory was 
not able to procure necessary serotyping reagents during the period 
under study, this is however regretted. Previous report has however 
shown the existence of serotypes 5, 19F and 4 circulating within our 
geographical region [2]. Antibiotic susceptibility pattern revealed 
that of the 9 isolates of s. pneumonia recovered, majority were 
resistant to at least 2 classes of antibiotics Table 3. This is a 
worrisome trend as there have been several reports of emerging 
beta-lactamase resistance in our study environment [13-15]. There 
has been evidence of the presence of plasmid transmissible multi 
resistant resistant bacteria isolates within hospital subjects, this puts 
pressure on colonsing otherwise susceptible bacteria and could be 





The current study has revealed relatively high rates of Invasive 
bacterial diseases, including Meningitis and Pneumonia in Abeokuta, 
southwest, Nigeria. Our inability to show the serotype distribution of 
isolated strains of S. pneumonia is however regretted. Our study 
has indicated an emerging multi-drug resistance MDR trend among 
s. pneumonia recovered in our study environment, this again calls 
for responsible antibiotic stewardship even among previously 
susceptible pathogens. Better s. pneumoniae detection methods 
particularly for Meningitis cases such as the 
Immunochormatographic antigen detection tests are advocated for 
routine use in other to increase detection of otherwise culture 
negative cases. We also call for more efforts from concerned 
authorities for increased surveillance against IPD in our environment 
and government's full inclusion of PCV-7 into the routine childhood 
immunisation programme. 
 
What is known about this topic 
 
• Invasive streptococcal diseases are an established disease 
condition in Nigeria, with a significant mortality rate. 
• Pneumococcal vaccine PCV 13 by GSK is already available 
for use in Nigeria. 
• There are diagnostic challenges regarding rapid detection 
of IPD particularly in cases of childhood meningitis. 
 
What this study adds 
 
• The current study reveals the presence of drug resistance 
streptococcus pnuemoniae in Abeokuta, Nigeria. 
• Our study highlights the importance of introduction of 
rapid diagnostic test to achieve faster detection and 
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Table 1: demographic distribution showing age and 
gender distribution of suspected/probable IPD cases 
and culture confirmed IPD cases 
Gender Probable cases 
N (%) 
Confirmed 
cases N (%) 
Male 187 (39.7) 3 (33.3) 
Female 284 (60.3) 6 (66.7) 
Age group     
>1 263 (55.8) 5 (55.6) 
1>15 173 (36.7) 2 (22.2) 
15> 35 (7.5) 2 (22.2) 
Total 471 (100) 9 (100) 
 
 
Table 2: distribution of bacteria isolates recovered from various Invasive 
bacteria diseases in relation to Clinical diagnosis including IPD isolates 
Organism Clinical diagnosis 
Septicaemia Pneumonia Meningitis 
Strep. Pneumonia 3 (2.7) 4 (66.7) 2 (33.3) 
Staph. Aureus 44 (41.5) 0 (0) 2 (33.3) 
E. coli 29 (27.4) 0 (0) 1 (16.6) 
Kleb. Pneumonia 15 (14.2) 2 (33.3) 0 (0) 
Others 15 (14.2) 0 (0) 1 (16.8) 























Figure 1: Bar gragh showing the distribution of probable and laboratory 
confirmed Invasive Bacteria disease cases at FMC Abeokuta 
 
Table 3: antibiotic susceptibility profile of Streptococcus pneumonia tested against  some commonly 
prescribed antibiotics in Abeokuta, Nigeria 
Age Diagnosis Sample Susceptibility 
      Susceptible Resistant 
2yrs Sepsis Blood Ery, Tet, Gen Amox, Amox/clav 
6mths Meningitis C,S,F Ery, Amox, Amox/clav Tet, Gen 
1wk Sepsis Blood Amox, Amox/clav, Gen Tet 
1yr Meningitis C.S.F Gen, Ery, Amox/clav Tet, Amox 
5yrs Pneumonia Throat swab Gen, Ery, Amox/clav Tet, Amox 
11yrs Pneumonia Aspirate Amox, Amox/clav, Ery Tet, Gen 
8yrs Pneumonia Aspirate Gen, Ery, Amox/clav Amox, Tet 
9mths Sepsis Blood Gen, Amox/clav Ery, Tet, Amox 
19yrs Pneumonia Aspirate Amox/clav Gen, Ery, Tet, Amox 
Keys: Ery- Erythromycin, Tet-Tetracycline, Gen-Gentamycin, Amox-Amoxcillin, Amox/clav-
Amoxicillin/clavunalate. 
NB: Antibiotics tested include Amox/clav 30μg, Erythromycin (25μg), Amoxicillin (25μg), Tetracyclie 
(30μg), Cotrimaxole (25μg), Gentamycin (10μg) produced by (Abtek biologicals UK.) 
